These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16669126)

  • 21. Influenza in Canada: 2006-2007 season.
    Reyes F; Aziz S; Li Y; Macey JF; Winchester B; Garner M; Huston P; King A
    Can Commun Dis Rep; 2008 Mar; 34(3):1-25. PubMed ID: 18404807
    [No Abstract]   [Full Text] [Related]  

  • 22. Statement on influenza vaccination for the 2007-2008 season. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2007 Jul; 33(ACS-7):1-38. PubMed ID: 17663034
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunogenicity and tolerability of inactivated flu vaccine in high risk and healthy children.
    Avila Aguero ML; Soriano-Fallas A; Umaña-Sauma MA; Ulloa-Gutierrez R; Arnoux S
    Medicina (B Aires); 2007; 67(4):351-9. PubMed ID: 17891930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influenza vaccination coverage among children and adults - United States, 2008-09 influenza season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(39):1091-5. PubMed ID: 19816396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influenza in Canada: 2001-2002 season.
    Macey JF; Tam TW; Li Y; Winchester B; Zabchuk P
    Can Commun Dis Rep; 2003 Mar; 29(6):45-59. PubMed ID: 12666540
    [No Abstract]   [Full Text] [Related]  

  • 26. Deaths following influenza vaccination--background mortality or causal connection?
    Kokia ES; Silverman BG; Green M; Kedem H; Guindy M; Shemer J
    Vaccine; 2007 Dec; 25(51):8557-61. PubMed ID: 18006121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skin testing to evaluate oculo-respiratory syndrome (ORS) associated with influenza vaccination during the 2000-2001 season.
    Skowronski DM; De Serres G; Hebert J; Stark D; Warrington R; Macnabb J; Shadmani R; Rochette L; MacDonald D; Patrick DM; Duval B
    Vaccine; 2002 Jun; 20(21-22):2713-9. PubMed ID: 12034097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimal allocation of pandemic influenza vaccine depends on age, risk and timing.
    Mylius SD; Hagenaars TJ; Lugnér AK; Wallinga J
    Vaccine; 2008 Jul; 26(29-30):3742-9. PubMed ID: 18524428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse ocular effects following influenza vaccination.
    Solomon A; Siganos CS; Frucht-Pery J
    Eye (Lond); 1999 Jun; 13 ( Pt 3a)():381-2. PubMed ID: 10624444
    [No Abstract]   [Full Text] [Related]  

  • 30. Influenza in Canada--1998-1999 season.
    Pelletier L; Buck P; Zabchuk P; Winchester B; Tam T
    Can Commun Dis Rep; 1999 Nov; 25(22):185-92. PubMed ID: 10624035
    [No Abstract]   [Full Text] [Related]  

  • 31. Statement on influenza vaccination for the 2006-2007 season. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2006 Jun; 32(ACS-7):1-27. PubMed ID: 16805064
    [No Abstract]   [Full Text] [Related]  

  • 32. Hospital-based influenza vaccination of children: an opportunity to prevent subsequent hospitalization.
    Zerr DM; Englund JA; Robertson AS; Marcuse EK; Garrison MM; Christakis DA
    Pediatrics; 2008 Feb; 121(2):345-8. PubMed ID: 18245426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Avoiding Guillan-Barré Syndrome following swine origin pandemic H1N1 2009 influenza vaccination.
    Eisen DP; McBryde ES
    J Infect Dis; 2009 Nov; 200(10):1627-8. PubMed ID: 19857155
    [No Abstract]   [Full Text] [Related]  

  • 34. Co-morbidities associated with influenza-attributed mortality, 1994-2000, Canada.
    Schanzer DL; Langley JM; Tam TW
    Vaccine; 2008 Aug; 26(36):4697-703. PubMed ID: 18620016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influenza vaccine 2008-2009.
    Med Lett Drugs Ther; 2008 Oct; 50(1296):77-9. PubMed ID: 18833032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guillain-Barré syndrome after influenza vaccination in adults: a population-based study.
    Juurlink DN; Stukel TA; Kwong J; Kopp A; McGeer A; Upshur RE; Manuel DG; Moineddin R; Wilson K
    Arch Intern Med; 2006 Nov; 166(20):2217-21. PubMed ID: 17101939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2002, through 31 December, 2003.
    Can Commun Dis Rep; 2006 Apr; 32(8):97-107. PubMed ID: 16685767
    [No Abstract]   [Full Text] [Related]  

  • 38. Recent changes in influenza vaccination recommendations, 2007.
    Zimmerman RK
    J Fam Pract; 2007 Feb; 56(2 Suppl Vaccines):S12-7, C1. PubMed ID: 17270107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of influenza vaccination in community pharmacies 2008-2009].
    De Bruyn K; Saevels J
    J Pharm Belg; 2009 Sep; (3):79-83. PubMed ID: 19873847
    [No Abstract]   [Full Text] [Related]  

  • 40. The effectiveness of national influenza vaccination policies for at-risk populations over 5 seasons in a Scottish general practice.
    Sivaprakasam V; Douglas J; Selvaraj S; MacIntyre S; Carman WF
    Vaccine; 2008 Jul; 26(29-30):3772-7. PubMed ID: 18524431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.